Ningshu Liu

Ningshu Liu

Company: Bayer

Job title: Head of Laboratory Immuno Oncology & Senior Director & Global Strategy Lead

Seminars:

Live Q&A – Ask the Speakers Your Burning Questions 2:30 pm

Read more

day: Day One

Alternative Dosing Schemes of Pan-PI3K Inhibitors to Engage an Anti-Cancer Immune Response 1:10 pm

Bayer’s Aliqopa is the only drug in its class to show inhibitory activity predominantly against PI3K alpha and PI3K-delta isoforms expressed in malignant B cells This presentation will explore key lessons around immune modulation, dosing schedule, safety, and combination strategyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.